Cargando…
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
Tumor necrosis factor-α (TNFα) antagonists have advanced the management of inflammatory bowel diseases patients leading to an improvement of patient's quality of life with the reduction of number of surgeries and hospitalizations. Despite these advances, many patients do not respond to the indu...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737871/ https://www.ncbi.nlm.nih.gov/pubmed/26741065 http://dx.doi.org/10.1038/ctg.2015.63 |